COMMITMENTS AND CONTINGENCIES

12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

NOTE 15: COMMITMENTS AND CONTINGENCIES

a. The Company is not a party to any litigation or other legal proceedings that the Company believes could reasonably be expected to have a material adverse effect on the Company’s business, results of operations and financial condition.

b. As of December 31, 2015, the Company and its subsidiaries had several non-cancelable operating leases, primarily for facilities and equipment. These leases generally contain renewal options and require the Company and its subsidiaries to pay all executory costs such as maintenance and insurance. In addition, the Company has several fixed service agreements with sub-contractors.

Rent expenses for the years ended December 31, 2013, 2014 and 2015, were $839, $955 and $1,394, respectively.

As of December 31, 2015, future purchase obligations and minimum rental commitments for leasehold properties and operating leases with non-cancelable terms are as follows:


	Minimum rental commitments for leasehold properties		Commitments for other lease obligations		Other purchase obligations		Total
2016	$	1,068	$	931	$	578	$	2,577
2017		1,111		—		—		1,111
2018		905		—		—		905
2019		211		—		—		211
2020		180		—		—		180

	$	3,475	$	931	$	578	$	4,984

c. Royalties:

The Company participated in programs sponsored by the Israeli government for the support of research and development activities. Through December 31, 2015, the Company had obtained grants from the Office of the Chief Scientist of the Israeli Ministry of Industry and Trade (the “OCS”) for certain of the Company’s research and development projects. The Company is obligated to pay royalties to the OCS, amounting to 3%-3.5% of the sales of the products and other related revenues (based on the dollar) generated from such projects, up to 100% of the grants received. Royalty payment obligations also bear interest at the LIBOR rate. The obligation to pay these royalties is contingent on actual sales of the products and in the absence of such sales, no payment is required.

Royalty expenses relating to the OCS grants included in cost of revenues for the years ended December 31, 2013, 2014 and 2015 amounted to $147, $300 and $482, respectively. As of December 31, 2015, the aggregate contingent liability to the OCS (including interest) amounted to $15,135.